Endpoint Clinical

Sr. Director, Business Development

United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Life Sciences, Pharmaceuticals, Biotechnology, SoftwareIndustries

Requirements

Candidates must possess a Bachelor's degree or equivalent experience, with 5-7 years of sales experience in IVR/IWR or pharmaceutical services. A proven track record in B2B software sales, the ability to understand and communicate technical concepts, and strong organizational, time management, and communication skills are essential. The role also requires the ability to work independently and as part of a team, with a methodical approach to prospecting.

Responsibilities

The Sr. Director, Business Development will identify, develop, and win U.S. business opportunities by selling clinical trials software to pharmaceutical and biotech companies. Responsibilities include achieving sales goals, establishing and maintaining client relationships, educating customers on the software's value, and maintaining accurate sales records. The role also involves preparing and delivering client presentations, generating quotes and proposals, participating in trade shows, and contributing to the creation of new sales plans and strategies.

Skills

Business Development
Sales
Client Relationship Management
Prospecting
Software Sales
Technical Concepts
Sales Pipeline Management
Quoting
Proposal Generation
Trade Shows
Sales Planning
Strategy
IVR/IWR
Pharmaceutical Services
Clinical Trials Software

Endpoint Clinical

Provides interactive response technology for clinical trials

About Endpoint Clinical

Endpoint Clinical provides interactive response technology (IRT) systems designed for clinical trials. Their systems assist with various trial processes such as managing drug supplies, randomizing patients, and scheduling visits. These systems are user-friendly and cater to clients in the life sciences sector, including pharmaceutical and biotechnology companies. Endpoint Clinical differentiates itself by focusing on ease of use and integration with other clinical trial management systems, ensuring that clients can streamline their processes and maintain regulatory compliance. The company's goal is to enhance the efficiency and transparency of clinical trials, allowing sponsors to conduct their research more effectively.

San Francisco, CaliforniaHeadquarters
2009Year Founded
$1.7MTotal Funding
DEBTCompany Stage
Enterprise Software, HealthcareIndustries
201-500Employees

Benefits

Remote Work Options

Risks

Emerging IRT providers with cost-effective solutions threaten Endpoint Clinical's market share.
Rapid AI advancements may outpace Endpoint Clinical's current technology offerings.
Decentralized trials could reduce demand for traditional IRT systems, impacting Endpoint's model.

Differentiation

Endpoint Clinical offers user-friendly IRT systems for clinical trial management.
The company specializes in drug supply management, patient randomization, and visit scheduling.
Endpoint Clinical collaborates with THREAD and Berlinger for integrated clinical trial solutions.

Upsides

Increased adoption of DCTs boosts demand for flexible IRT systems like Endpoint Clinical's.
AI integration in clinical trials offers Endpoint opportunities for advanced analytics.
Personalized medicine trends require sophisticated IRT solutions, benefiting Endpoint Clinical.

Land your dream remote job 3x faster with AI